![]() |
Volumn 11, Issue 9, 2010, Pages 819-820
|
Angiotensin-receptor blockade, cancer, and concerns
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANGIOTENSIN 1 RECEPTOR;
ANGIOTENSIN 1 RECEPTOR ANTAGONIST;
ANGIOTENSIN 2 RECEPTOR;
ANGIOTENSIN RECEPTOR ANTAGONIST;
ATENOLOL;
PLACEBO;
RAMIPRIL;
TELMISARTAN;
CANCER INCIDENCE;
CANCER RISK;
CARDIOVASCULAR DISEASE;
CLINICAL TRIAL;
DRUG INDICATION;
HUMAN;
LETTER;
MALIGNANT NEOPLASTIC DISEASE;
PRIORITY JOURNAL;
RISK BENEFIT ANALYSIS;
SOLID TUMOR;
TREATMENT DURATION;
CHEMICALLY INDUCED DISORDER;
META ANALYSIS;
METHODOLOGY;
NEOPLASM;
NOTE;
ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS;
CLINICAL TRIALS AS TOPIC;
HUMANS;
META-ANALYSIS AS TOPIC;
NEOPLASMS;
RESEARCH DESIGN;
|
EID: 77956160730
PISSN: 14702045
EISSN: None
Source Type: Journal
DOI: 10.1016/S1470-2045(10)70178-9 Document Type: Letter |
Times cited : (7)
|
References (5)
|